Vasculitic neuropathy

Handbook of Clinical Neurology

Volumn 115, Issue , 2013, Pages 463-483

  Vrancken, Alexander F J E ^a   Said, Gérard ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Mononeuritis multiplex; Mononeuropathy multiplex; Peripheral neuropathy; Vasculitic neuropathy; Vasculitis

Indexed keywords

ARTICLE; HUMAN; MONONEUROPATHY MULTIPLEX; PERIPHERAL NEUROPATHY; VASCULITIC NEUROPATHY; VASCULITIS;

MONONEURITIS MULTIPLEX; MONONEUROPATHY MULTIPLEX; PERIPHERAL NEUROPATHY; VASCULITIC NEUROPATHY; VASCULITIS;

HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; VASCULITIS;

EID: 84881513145     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52902-2.00026-6     Document Type: Chapter

References (215)

1. Agadi J.B., Raghav G., Mahadevan A., et al. Usefulness of superficial peroneal nerve/peroneus brevis muscle biopsy in the diagnosis of vasculitic neuropathy. J Clin Neurosci 2012, 19:1392-1396.
2. Agard C., Mouthon L., Mahr A., et al. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?. Arthritis Rheum 2003, 49:709-715.
3. Agarwal V., Singh R., Wiclaf, et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 2008, 27:841-844.
4. Alard J.E., Dueymes M., Youinou P., et al. HSP60 and anti-HSP60 antibodies in vasculitis: they are two of a kind. Clin Rev Allergy Immunol 2008, 35:66-71.
5. Andrade R., Moya Machado A., Gomez Conde S., et al. Neuropatías por vasculitis en la infancia. Rev Neurol 2004, 38:619-624.
6. Antoine J.C., Mosnier J.F., Absi L., et al. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999, 67:7-14.
7. Authier F.J., Bassez G., Payan C., et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003, 60:808-812.
8. Baldini C., Della Rossa A., Grossi S., et al. Caratteristiche clinico-sierologiche e dati di outcome di una casistica monocentrica di pazienti affetti da sindrome di Churg-Strauss. Reumatismo 2009, 61:118-124.
9. Ball G.V., Bridges S.L. Pathogenesis of vasculitis. Vasculitis 2008, 67-88. Oxford University Press, New York, Chapter 7. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
10. Becker-Merok A., Nossent J. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus. Lupus 2009, 18:508-515.
11. Beggs J., Johnson P.C., Olafsen A., et al. Transperineurial arterioles in human sural nerve. J Neuropathol Exp Neurol 1991, 50:704-718.
12. Bennett D.L.H., Groves M.J., Blake J., et al. The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. J Neurol Neurosurg Psychiatry 2008, 79:1376-1381.
13. Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010, 16:287-297.
14. Boddaert J., Huong D.L., Amoura Z., et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 2004, 83:348-359.
15. Bodolay E., Csiki Z., Szekanecz Z., et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003, 21:313-320.
16. Bonetti B., Invernizzi F., Rizzuto N., et al. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol 1997, 73:145-154.
17. Borchers A.T., Naguwa S.M., Shoenfeld Y., et al. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010, 9:A277-A287.
18. Bouche P., Léger J.M., Travers M.A., et al. Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology 1986, 36:1598-1602.
19. Briemberg H.R., Levin K., Amato A.A. Multifocal conduction block in peripheral nerve vasculitis. J Clin Neuromuscul Dis 2002, 3:153-158.
20. Broglio L., Erne B., Tolnay M., et al. Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy. Muscle Nerve 2008, 38:1272-1279.
21. Calore E.E., Shulte G., Penalva De Oliveira A.C., et al. Nerve biopsy in patients with AIDS. Pathologica 1998, 90:31-35.
22. Carlson J.A., Chen K.R. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J Dermatopathol 2006, 28:486-506.
23. Caselli R.J., Daube J.R., Hunder G.G., et al. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 1988, 38:685-689.
24. Cassereau J., Baguenier-Desormeaux C., Letournel F., et al. Necrotizing vasculitis revealed in a case of multiple mononeuropathy after a 14-year course of spontaneous remissions and relapses. Clin Neurol Neurosurg 2012, 14:290-293.
25. Cattaneo L., Chierici E., Pavone L., et al. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry 2007, 78:1119-1123.
26. Chang R.W., Bell C.L., Hallett M. Clinical characteristics and prognosis of vasculitic mononeuropathy multiplex. Arch Neurol 1984, 41:618-621.
27. Chia L., Fernandez A., Lacroix C., et al. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly: a retrospective review of 100 consecutive patients. Brain 1996, 119:1091-1098.
28. Chimelli L., Freitas M., Nascimento O. Value of nerve biopsy in the diagnosis and follow-up of leprosy: the role of vascular lesions and usefulness of nerve studies in the detection of persistent bacilli. J Neurol 1997, 244:318-323.
29. Churg A. Pathologic features of vasculitis. Vasculitis 2008, 97-114. Oxford University Press, New York, Chapter 9. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
30. Cid M.C., Grau J.M., Casademont J., et al. Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa. Arthritis Rheum 1994, 37:1055-1061.
31. Claussen G.C., Thomas T.D., Goyne C., et al. Diagnostic value of nerve and muscle biopsy in suspected vasculitis cases. J Clin Neuromusc Dis 2000, 1:117-123.
32. Collins M.P. The vasculitic neuropathies: an update. Curr Opin Neurol 2012, 25:573-585.
33. Collins M.P., Periquet M.I. Isolated vasculitis of the peripheral nervous system. Clin Exp Rheumatol 2008, 26:S118-S130.
34. Collins M.P., Mendell J.R., Periquet M.I., et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000, 55:636-643.
35. Collins M.P., Periquet M.I., Mendell J.R., et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology 2003, 61:623-630.
36. Collins M.P., Dyck P.J., Gronseth G.S., et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010, 15:176-184.
37. Collins M.P., Periquet-Collins I., Sahenk Z., et al. Direct immunofluorescence in vasculitic neuropathy: specificity of vascular immune deposits. Muscle Nerve 2010, 42:62-69.
38. Coll-Vinent B., Cebrian M., Cid M.C., et al. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 1998, 41:435-444.
39. Creange A., Saint-Val C., Guillevin L., et al. Peripheral neuropathies after arthropod stings not due to Lyme disease: a report of five cases and review of the literature. Neurology 1993, 43:1483-1488.
40. Cruz Martinez A., Barbado F.J., Ferrer M.T., et al. Electrophysiological study in systemic necrotizing vasculitis of the polyarteritis nodosa group. Electromyogr Clin Neurophysiol 1988, 28:167-173.
41. Davies L., Spies J.M., Pollard J.D., et al. Vasculitis confined to peripheral nerves. Brain 1996, 119:1441-1448.
42. de Groot K., Schmidt D.K., Arlt A.C., et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001, 58:1215-1221.
43. de Souza F.H., Radu Halpern A.S., Valente Barbas C.S., et al. Wegener's granulomatosis: experience from a Brazilian tertiary center. Clin Rheumatol 2010, 29:855-860.
44. Delalande S., de Seze J., Fauchais A.L., et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine 2004, 83:280-291.
45. Della Rossa A., Baldini C., Tavoni A., et al. Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology (Oxford) 2002, 41:1286-1294.
46. Deprez M., de Groote C.C., Gollogly L., et al. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul Disord 2000, 10:92-98.
47. Djukic M., Schmidt H., Mazurek C., et al. A patient with Churg-Strauss syndrome presenting as Guillain-Barre syndrome. Nervenarzt 2008, 79:457-461.
48. Drenkard C., Villa A.R., Reyes E., et al. Vasculitis in systemic lupus erythematosus. Lupus 1997, 6:235-242.
49. Dyck P.J., Conn D.L., Okazaki H. Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc 1972, 47:461-475.
50. Dyck P.J., Benstead T.J., Conn D.L., et al. Nonsystemic vasculitic neuropathy. Brain 1987, 110:843-853.
51. Dyck P.J., Hunder G.G., Dyck P.J. A case-control and nerve biopsy study of CREST multiple mononeuropathy. Neurology 1997, 49:1641-1645.
52. Dyck P.J., Engelstad J.K., Norell J., et al. Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 2000, 59:525-538.
53. Edvardsson B., Eriksson B. Giant cell arteritis and bilateral peroneal nerve palsy. Scand J Rheumatol 2010, 39:269-270.
54. Fain O., Hamidou M.A., Cacoub P.P., et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 2007, 57:1473-1480.
55. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008, 3:25.
56. Florica B., Aghdassi E., Su J., et al. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2011, 41:203-211.
57. Fujimura H., Lacroix C., Said G. Vulnerability of nerve fibres to ischaemia: a quantitative light and electron microscope study. Brain 1991, 114:1929-1942.
58. Gao Y., Zhao M.H. Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 2009, 14:33-41.
59. Genta M.S., Genta R.M., Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 2006, 36:88-98.
60. Gherardi R.K., Belec L., Mhiri C., et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients: a clinicopathologic evaluation. Arthritis Rheum 1993, 36:1164-1174.
61. Golbus J., McCune W.J. Giant cell arteritis and peripheral neuropathy: a report of 2 cases and review of the literature. J Rheumatol 1987, 14:129-134.
62. Gonzalez Quijada S., Sevil Puras M., Valledor A.R., et al. Análisis clínico de 91 casos de vasculitis de mediano y pequeño vaso en adultos. An Med Interna (Madrid) 2003, 20:461-465.
63. Grant I.A., Hunder G.G., Homburger H.A., et al. Peripheral neuropathy associated with sicca complex. Neurology 1997, 48:855-862.
64. Gross W.L., Csernok E. Wegener's granulomatosis: clinical and immunodiagnostic aspects. Vasculitis 2008, 403-413. Oxford University Press, New York, Chapter 31. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
65. Guillevin L., Cohen P., Gayraud M., et al. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine 1999, 78:26-37.
66. Guillevin L., Durand-Gasselin B., Cevallos R., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42:421-430.
67. Guillevin L., Cohen P., Mahr A., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003, 49:93-100.
68. Guillevin L., Mahr A., Callard P., et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine 2005, 84:313-322.
69. Guillevin L., Pagnoux C., Teixeira L. Microscopic polyangiitis. Vasculitis 2008, 355-364. Oxford University Press, New York, Chapter 27. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
70. Gurer G., Erdem S., Kocaefe C., et al. Expression of matrix metalloproteinases in vasculitic neuropathy. Rheumatol Int 2004, 24:255-259.
71. Hamidou M.A., Moreau A., Toquet C., et al. Temporal arteritis associated with systemic necrotizing vasculitis. J Rheumatol 2003, 30:2165-2169.
72. Harati Y., Niakan E. Clinical significance of selective nerve fascicular degeneration on sural nerve biopsy specimen. Arch Pathol Lab Med 1986, 110:195-197.
73. Hattori N., Ichimura M., Nagamatsu M., et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 1999, 122:427-439.
74. Hattori N., Mori K., Misu K., et al. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatol 2002, 29:1408-1414.
75. Hawke S.H., Davies L., Pamphlett R., et al. Vasculitic neuropathy: a clinical and pathological study. Brain 1991, 114:2175-2190.
76. Hicks J.T., Korenyi-Both A., Utsinger P.D., et al. Neuromuscular and immunochemical abnormalities in an adult man with Kawasaki disease. Ann Intern Med 1982, 96:607-610.
77. Hilton D.A., Jacob J., Househam L., et al. Complications following sural and peroneal nerve biopsies. J Neurol Neurosurg Psychiatry 2007, 78:1271-1272.
78. Hoke A., Sun H.S., Gordon T., et al. Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum. Exp Neurol 2001, 172:398-406.
79. Hughes L.B. Vasculitis in connective tissue diseases. Vasculitis 2008, 439-460. Oxford University Press, New York, Chapter 34. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
80. Hunzelmann N., Genth E., Krieg T., et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008, 47:1185-1192.
81. Ito T., Kijima M., Watanabe T., et al. Ultrasonography of the tibial nerve in vasculitic neuropathy. Muscle Nerve 2007, 35:379-382.
82. Jardim M.R., Antunes S.L., Santos A.R., et al. Criteria for diagnosis of pure neural leprosy. J Neurol 2003, 250:806-809.
83. Kadiyala R.K., Ramirez A., Taylor A.E., et al. The blood supply of the common peroneal nerve in the popliteal fossa. J Bone Joint Surg Br 2005, 87:337-342.
84. Kararizou E., Davaki P., Karandreas N., et al. Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases. J Rheumatol 2005, 32:853-858.
85. Kararizou E., Davaki P., Karandreas N., et al. Polyneuropathies in the elderly: a clinico pathological study of 74 cases. Int J Neurosci 2006, 116:629-638.
86. Kawamura N., Dyck P.J., Schmeichel A.M., et al. Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculoplexus neuropathy. Acta Neuropathol 2008, 115:231-239.
87. Kelkar P., Masood M., Parry G.J. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 2000, 55:83-88.
88. Kermani T.A., Ham E.K., Camilleri M.J., et al. Polyarteritis nodosa-like vasculitis in association with minocycline use: a single-center case series. Semin Arthritis Rheum 2012, 42:213-221.
89. Kernohan J.W., Woltman H.W. Periarteritis nodosa: a clinicopathologic study with special reference to the nervous system. Arch Neurol Psychiatry 1938, 39:655-686.
90. Khalili-Shirazi A., Gregson N.A., Londei M., et al. The distribution of CD1 molecules in inflammatory neuropathy. J Neurol Sci 1998, 158:154-163.
91. Khellaf M., Hamidou M.A., Pagnoux C., et al. Vasculitis restricted to the lower limbs: a clinical and histopathological study. Ann Rheum Dis 2007, 66:554-556.
92. Kimber T.E., Scott G., Thompson P.D., et al. Vasculitic neuropathy and myopathy occurring as a complication of mixed connective tissue disease. Aust N Z J Med 1999, 29:82-83.
93. Kinter J., Broglio L., Steck A.J., et al. Gene expression profiling in nerve biopsy of vasculitic neuropathy. J Neuroimmunol 2010, 225:184-189.
94. Kissel J.T., Slivka A.P., Warmolts J.R., et al. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol 1985, 18:251-257.
95. Kozu H., Tamura E., Parry G.J. Endoneurial blood supply to peripheral nerves is not uniform. J Neurol Sci 1992, 111:204-208.
96. Klein C.J., Dyck P.J., Friedenberg S.M., et al. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry 2002, 73:45-50.
97. Kumazawa K., Sobue G., Aizawa I., et al. Autonomic dysfunction in vasculitic neuropathy: special reference to sudomotor function. Rinsho Shinkeigaku 1990, 30:599-604.
98. Kurzrock R., Cohen P.R., Markowitz A. Clinical manifestations of vasculitis in patients with solid tumors: a case report and review of the literature. Arch Intern Med 1994, 154:334-340.
99. Lapraik C., Watts R.A., Bacon P.A., et al. BSR and BHPR guidelines for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 2007, 46:1615-1616.
100. Laskari K., Ahmadi-Simab K., Lamken M., et al. Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis?. Ann Rheum Dis 2010, 69:469-471.
101. Lee J.E., Shun C.T., Hsieh S.C., et al. Skin denervation in vasculitic neuropathy. Arch Neurol 2005, 62:1570-1573.
102. Lidar M., Lipschitz N., Langevitz P., et al. The infectious etiology of vasculitis. Autoimmunity 2009, 42:432-438.
103. Liu L.J., Chen M., Yu F., et al. Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 2008, 47:708-712.
104. Llewelyn J.G., Thomas P.K., King R.H. Epineurial microvasculitis in proximal diabetic neuropathy. J Neurol 1998, 245:159-165.
105. Marcaud V., Gauthier C., Maisonobe T., et al. Vascularite restreinte au système nerveux périphérique: présentation clinique atypique. Rev Med Interne 2002, 23:558-562.
106. Mathew L., Talbot K., Love S., et al. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM 2007, 100:41-51.
107. Maugeri N., Rovere-Querini P., Baldini M., et al. Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin Exp Immunol 2009, 156:395-404.
108. Mawrin C., Schütz G., Schröder J.M. Correlation between the number of epineurial and endoneurial blood vessels in diseased human sural nerves. Acta Neuropathol 2001, 102:364-372.
109. Mawrin C., Brunn A., Rocken C., et al. Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol 2003, 105:365-372.
110. Mellgren S.I., Conn D.L., Stevens J.C., et al. Peripheral neuropathy in primary Sjögren's syndrome. Neurology 1989, 39:390-394.
111. Midroni G., Cohen S.M., Bilbao J.M. Endoneurial vasculitis and tubuloreticular inclusions in peripheral nerve biopsy. Clin Neuropathol 2000, 19:70-76.
112. Mikdashi J., Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 2004, 43:1555-1560.
113. Mikusek J., Karamnska W., Karmanski A. Vascularization of the human sciatic nerve fasciculi. Folia Morphol (Warsz) 1997, 56:175-181.
114. Molyneux P.D., Barker R., Thomas P.K., et al. Non-systemic vasculitic neuropathy presenting with a painful polyradiculopathy: a case report. J Neurol 2000, 247:645-646.
115. Monach P.A., Merkel P.A. Genetics of vasculitis. Curr Opin Rheumatol 2010, 22:157-163.
116. Morozumi S., Koike H., Tomita M., et al. Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. J Neuropathol Exp Neurol 2011, 70:340-348.
117. Moore P.M., Harley J.B., Fauci A.S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985, 102:109-114.
118. Mori K., Iijima M., Koike H., et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005, 128:2518-2534.
119. Mukhtyar C., Guillevin L., Cid M.C., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317.
120. Nakamura M., Yabe I., Yaguchi H., et al. Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy. Clin Neurol Neurosurg 2009, 111:683-687.
121. Nascimento O., De Freitas M.R., Chimelli L., et al. Peripheral neuropathy in hypereosinophilic syndrome with vasculitis. Arq Neuropsiquiatr 1991, 49:450-455.
122. Nemni R., Sanvito L., Quattrini A., et al. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003, 74:1267-1271.
123. Nicolai A., Bonetti B., Lazzarino L.G., et al. Peripheral nerve vasculitis: a clinico-pathological study. Clin Neuropathol 1995, 14:137-141.
124. Nishino H., Rubino F.A., DeRemee R.A., et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993, 33:4-9.
125. Nodera H., Sato K., Terasawa Y., et al. High-resolution sonography detects inflammatory changes in vasculitic neuropathy. Muscle Nerve 2006, 34:380-381.
126. Nukada H., Dyck P.J., Karnes J.L. Spatial distribution of capillaries in rat nerves: correlation to ischemic damage. Exp Neurol 1985, 87:369-376.
127. Nukada H., Anderson G.M., McMorran P.D. Reperfusion nerve injury: pathology due to reflow and prolonged ischaemia. J Peripher Nerv Syst 1997, 2:60-69.
128. Ogawa N., Kawai H., Yamakawa I., et al. A case of minocycline-induced vasculitic neuropathy. Rinsho Shinkeigaku 2010, 50:301-305.
129. Oh S.J. Diagnostic usefulness and limitations of the sural nerve biopsy. Yonsei Med J 1990, 31:1-26.
130. Oh S.J. Vasculitic neuropathy. Vasculitis 2008, 161-180. Oxford University Press, New York, Chapter 14. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
131. Ohkoshi N., Mizusawa H., Oguni E., et al. Sural nerve biopsy in vasculitic neuropathies: morphometric analysis of the caliber of involved vessels. J Med 1996, 27:153-170.
132. Oka N., Kawasaki T., Mizutani K., et al. Hypoxia-inducible factor 1alpha may be a marker for vasculitic neuropathy. Neuropathology 2007, 27:509-515.
133. Oka N., Kawasaki T., Matsui M., et al. Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA. Mod Rheumatol 2011, 21:290-295.
134. Orton D.I., Whittaker S.J. Renal angiogram abnormalities in a case of cutaneous polyarteritis nodosa. Clin Exp Dermatol 2000, 25:33-35.
135. Pagnoux C., Guilpain P., Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007, 19:25-32.
136. Pagnoux C., Seror R., Henegar C., et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010, 62:616-626.
137. Panda A., Arjona A., Sapey E., et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333.
138. Pary L.F., Henszel A., Kelkar P. Vasculitic mononeuritis multiplex induced by valacyclovir. Neurology 2004, 62:1906-1907.
139. Plumley S.G., Rubio R., Alasfar S., et al. Polyarteritis nodosa presenting as polymyositis. Semin Arthritis Rheum 2002, 31:377-383.
140. Prayson R.A., Sedlock D.J. Clinicopathologic study of 43 patients with sural nerve vasculitis. Hum Pathol 2003, 34:484-490.
141. Probst-Cousin S., Neundörfer B., Heuss D. Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors. Neuromuscul Disord 2010, 20:192-197.
142. Puéchal X., Said G., Hilliquin P., et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis: a clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995, 38:1618-1629.
143. Ramchandren S., Chaudhry V., Hoke A., et al. Peripheral nerve vasculitis presenting as complex regional pain syndrome. J Clin Neuromuscul Dis 2008, 10:61-64.
144. Ramos-Casals M., Nardi N., Lagrutta M., et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine 2006, 85:95-104.
145. Ramos-Casals M., Solans R., Rosas J., et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008, 87:210-219.
146. Ramos-Casals M., Roberto-Perez-Alvarez Diaz-Lagares C., et al. Autoimmune diseases induced by biological agents: a double-edged sword?. Autoimmun Rev 2010, 9:188-193.
147. Renaud S., Erne B., Fuhr P., et al. Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies. Acta Neuropathol 2003, 105:37-42.
148. Restrepo J.F., Rondon F., Matteson E.L., et al. Necrotizing lymphocytic vasculitis limited to the peripheral nerves: report of six cases and review. Int J Rheumatol 2009, 368032. Published online March 1 2010. 10.1155/2009/368032.
149. Ribi C., Cohen P., Pagnoux C., et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum 2008, 58:586-594.
150. Ribi C., Cohen P., Pagnoux C., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 2010, 62:1186-1197.
151. Rios Blanco J.J., Gomez Cerezo J., Suarez Garcia I., et al. Churg-Strauss syndrome: our experience in 2 decades. Rev Clin Esp 2000, 200:597-601.
152. Riva N., Cerri F., Butera C., et al. Churg-Strauss syndrome presenting as acute neuropathy resembling Guillain-Barre syndrome: case report. J Neurol 2008, 255:1843-1844.
153. Robinson-Papp J., Simpson D.M. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 2009, 40:1043-1053.
154. Ropert A., Metral S. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve 1990, 13:102-105.
155. Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve 2001, 24:154-169.
156. Saadoun D., Bieche I., Maisonobe T., et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 2005, 52:2917-2925.
157. Saadoun D., Sellam J., Ghillani-Dalbin P., et al. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 2006, 166:2101-2108.
158. Saadoun D., Bieche I., Authier F.J., et al. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 2007, 56:1315-1324.
159. Saadoun D., Terrier B., Semoun O., et al. Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res (Hoboken) 2011, 63:427-435.
160. Said G. Necrotizing peripheral nerve vasculitis. Neurol Clin 1997, 15:835-848.
161. Said G. Infectious neuropathies. Neurol Clin 2007, 25:115-137.
162. Said G., Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005, 252:633-641.
163. Said G., Lacroix-Ciaudo C., Fujimura H., et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol 1988, 23:461-465.
164. Said G., Lacroix C., Lozeron P., et al. Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain 2003, 126:376-385.
165. Sarikcioglu L., Demirel B.M., Demir N., et al. Morphological and ultrastructural analysis of the watershed zones after stripping of the vasa nervorum. Int J Neurosci 2008, 118:1145-1155.
166. Schäfers M., Neukirchen S., Toyka K.V., et al. Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J Peripher Nerv Syst 2008, 13:81-91.
167. Schneider H.A., Yonker R.A., Katz P., et al. Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum 1985, 14:280-286.
168. Schönermarck U., Lamprecht P., Csernok E., et al. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 2001, 40:178-184.
169. Schweikert K., Fuhr P., Probst A., et al. Contribution of nerve biopsy to unclassified neuropathy. Eur Neurol 2007, 57:86-90.
170. Sehgal M., Swanson J.W., DeRemee R.A., et al. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995, 70:337-341.
171. Seo J.H., Ryan H.F., Claussen G.C., et al. Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study. Neurology 2004, 63:874-878.
172. Servioli L., Perez C., Consani S., et al. Prevalence and characteristics of immunomediated neuropathies in a group of patients with autoimmune diseases. J Clin Neuromuscul Dis 2007, 9:285-290.
173. Singhal B.S., Khadilkar S.V., Gursahani R.D., et al. Vasculitic neuropathy: profile of twenty patients. J Assoc Physicians India 1995, 43:459-461.
174. Sobue G., Nakao N., Kumazawa K., et al. Migrating multiple mononeuritis and nonsystemic angitis. Rinsho Shinkeigaku 1989, 29:1210-1215.
175. Sokumbi O., Wetter D.A., Makol A., et al. Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clin Proc 2012, 87:739-745.
176. Solans R., Bosch J.A., Perez-Bocanegra C., et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford) 2001, 40:763-771.
177. Solans-Laque R., Bosch Gil J.A., Perez-Bocanegra C., et al. Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 2008, 35:294-304.
178. Solomon D.H., Kavanaugh A.J., Schur P.H., et al. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002, 47:434-444.
179. Souayah N., Sander H.W., Menkes D.L., et al. Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide. Neurol Neurophysiol Neurosci 2006, 18:5.
180. Stafford C.R., Bogdanoff B.M., Green L., et al. Mononeuropathy multiplex as a complication of amphetamine angiitis. Neurology 1975, 25:570-572.
181. Stefurak T.L., Midroni G., Bilbao J.M. Vasculitic polyradiculopathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1999, 66:658-661.
182. Stinton L.M., Fritzler M.J. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 2007, 7:77-84.
183. Stübgen J.P. Interferon alpha and neuromuscular disorders. J Neuroimmunol 2009, 207:3-17.
184. Sugiura M., Koike H., Iijima M., et al. Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: a comparative study. J Neurol Sci 2006, 241:31-37.
185. Suppiah R., Hadden R.D., Batra R., Arden N.K., et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 2011, 50:2214-2222.
186. Szekanecz Z., Koch A.E. Biology of endothelial cells. Vasculitis 2008, 35-45. Oxford University Press, New York, Chapter 4. 2nd edn. G.V. Ball, S.L. Bridges (Eds.).
187. Tai Y.J., Chong A.H., Williams R.A., et al. Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis. Australas J Dermatol 2006, 47:92-96.
188. Taieb G., Maisonobe T., Musset L., et al. Corrélations anatomocliniques des neuropathies périphériques cryoglobulinémiques secondaires à l'hépatite C. Série consécutive de 22 cas 2010, 166:509-514. Rev Neurol (Paris).
189. Terrier B., Lacroix C., Guillevin L., et al. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis Rheum 2007, 57:1520-1529.
190. The Wegener's Granulomatosis Etanercept Trial Research Group Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003, 48:2299-2309.
191. Theander E., Jacobsson L.T. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008, 34:935-947.
192. Tsubata T., Kumagai S., Ishida H., et al. A case of Behçet's disease with mononeuritis multiplex due to vasculitis. Jpn J Clin Immunol 1989, 12:135-141.
193. Tsunemi T., Yokota T., Kikyo H., et al. Nonsystemic vasculitic neuropathy presenting with truncal segmental sensory disturbance and hyperhidrosis. Muscle Nerve 1999, 22:646-647.
194. Turesson C., Matteson E.L. Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol 2009, 21:35-40.
195. Uçeyler N., Devigili G., Toyka K.V., et al. Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathol 2010, 120:109-116.
196. Uchiyama M., Mitsuhashi Y., Yamazaki M., et al. Elderly cases of Churg-Strauss syndrome: case report and review of Japanese cases. J Dermatol 2012, 39:76-79.
197. Venhuizen A., Tekstra J. Abnormal chest X-ray in a patient with mononeuritis multiplex. Neth J Med 2010, 68:91-92.
198. Villa-Forte A., Clark T.M., Gomes M., et al. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine 2007, 86:269-277.
199. Villa-Forte A. European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis. Curr Opin Rheumatol 2010, 22:49-53. European League Against Rheumatism, European Vasculitis Study Group.
200. Vital A., Vital C., Viallard J.F., et al. Neuro-muscular biopsy in Churg-Strauss syndrome: 24 cases. J Neuropathol Exp Neurol 2006, 65:187-192.
201. Vital C., Vital A., Canron M.H., et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy: a 16-year retrospective study of 202 cases. J Peripher Nerv Syst 2006, 11:20-29.
202. Vital A., Lagueny A., Ferrer X., et al. Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature. Clin Neuropathol 2008, 27:96-105.
203. Voskuyl A.E., Hazes J.M., Zwinderman A.H., et al. Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 2003, 62:407-413.
204. Voss E.V., Stangel M. Nervous system involvement of connective tissue disease: mechanisms and diagnostic approach. Curr Opin Neurol 2012, 25:306-315.
205. Vrancken A.F.J.E., Notermans N.C., Jansen G.H., et al. Progressive idiopathic axonal neuropathy: a comparative clinical and histopathological study with vasculitic neuropathy. J Neurol 2004, 251:269-278.
206. Vrancken A.F.J.E., Hughes R.A., Said G., et al. Immunosuppressive treatment for non-systemic vasculitic neuropathy. Cochrane Database Syst Rev 2007, 1. CD006050.
207. Vrancken A.F.J.E., Gathier C.S., Cats E.A., et al. The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy. Eur J Neurol 2010, 18:49-58.
208. Walker L.J., Swallow M.W., Mirakhur M. Behçet's disease presenting with mononeuritis multiplex. Ulster Med J 1990, 59:206-210.
209. Wees S.J., Sunwoo I.N., Oh S.J. Sural nerve biopsy in systemic necrotizing vasculitis. Am J Med 1981, 71:525-532.
210. Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol 2008, 20:35-39.
211. Wolf J., Bergner R., Mutallib S., et al. Neurologic complications of Churg-Strauss syndrome: a prospective monocentric study. Eur J Neurol 2010, 17:582-588.
212. Yamamoto M., Ito Y., Mitsuma N., et al. Pathology-related differential expression regulation of NGF, GDNF, CNTF, and IL-6 mRNAs in human vasculitic neuropathy. Muscle Nerve 2001, 24:830-833.
213. Zhang W., Zhou G., Shi Q., et al. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 2009, 27:S65-S69.
214. Živković S.A., Ascherman D., Lacomis D. Vasculitic neuropathy: electrodiagnostic findings and association with malignancies. Acta Neurol Scand 2007, 115:432-436.
215. Zwinderman A.H., Voskuyl A.E., Schelhaas D.D., et al. Diagnostic strategies for the histological examination of muscle biopsy specimens for the assessment of vasculitis in rheumatoid arthritis. Stat Med 2000, 19:3433-3447.